BIGG

Pan-American Guidelines for the Treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API) [Pré-print]

Barbosa, Alexandre Naime; Chebabo, Alberto; Pérez, Clevy; Cunha, Clóvis Arns; Luna, David de; Nunes, Estevão Portela; Zambrano, Gabriela; Ferreira, Juliana Carvalho; Croda, Júlio; Falavigna, Maicon; Silva, Monica Maria Gomes da; Cimerman, Sergio; Parahiba, Suena Medeiros; Tanni, Suzana; Bernardo, Wanderley Marques; Rodriguez-Morales, Alfonso J.

Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been investigated at different stages of clinical manifestations. Considering the particular impact of COVID-19 in the Americas, this document aims to present recommendations for the pharmacological treatment of ...

COVID-19/tratamiento farmacológico, SARS-CoV-2/efectos de los fármacos, Antivirales/uso terapéutico, Anticuerpos Monoclonales/uso terapéutico, Hidroxicloroquina/uso terapéutico, Cloroquina/uso terapéutico

Texto completo (enlace principal) Texto completo (enlace alternativo)

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version)

Jin, Ying-Hui; Zhan, Qing-Yuan; Peng, Zhi-Yong; Ren, Xue-Qun; Yin, Xun-Tao; Cai, Lin; Yuan, Yu-Feng; Yue, Ji-Rong; Zhang, Xiao-Chun; Yang, Qi-Wen; Ji, Jianguang; Xia, Jian; Li, Yi-Rong; Zhou, Fu-Xiang; Gao, Ya-Dong; Yu, Zhui; Xu, Feng; Tu, Ming-Li; Tan, Li-Ming; Yang, Min; Chen, Fang; Zhang, Xiao-Ju; Zeng, Mei; Zhu, Yu; Liu, Xin-Can; Yang, Jian; Zhao, Dong-Chi; Ding, Yu-Feng; Hou, Ning; Wang, Fu-Bing; Chen, Hao; Zhang, Yong-Gang; Li, Wei; Chen, Wen; Shi, Yue-Xian; Yang, Xiu-Zhi; Wang, Xue-Jun; Zhong, Yan-Jun; Zhao, Ming-Juan; Li, Bing-Hui; Ma, Lin-Lu; Zi, Hao; Wang, Na; Wang, Yun-Yun; Yu, Shao-Fu; Li, Lu-Yao; Huang, Qiao; Weng, Hong; Ren, Xiang-Ying; Luo, Li-Sha; Fan, Man-Ru; Huang, Di; Xue, Hong-Yang; Yu, Lin-Xin; Gao, Jin-Ping; Deng, Tong; Zeng, Xian-Tao; Li, Hong-Jun; Cheng, Zhen-Shun; Yao, Xiaomei; Wang, Xing-Huan.

Mil. med. res. (Lond.); 7 (41), 2020

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis and treatment guidelines for clinicians caring for patients are needed. In the ...

Quimioprevención/métodos, Infecciones por Coronavirus/diagnóstico, Infecciones por Coronavirus/tratamiento farmacológico, Neumonía Viral/diagnóstico, Neumonía Viral/tratamiento farmacológico, Pandemias/prevención & control, Betacoronavirus/efectos de los fármacos, Práctica Clínica Basada en la Evidencia/métodos, Antirretrovirales/uso terapéutico, Lopinavir/uso terapéutico, Cloroquina/uso terapéutico, Receptores de Interleucina-6/uso terapéutico, Hidroxicloroquina/uso terapéutico, Plasma/inmunología

Texto completo

Chinese Guidelines related to Novel Coronavirus Pneumonia

Qiu, Tingting; Liang, Shuyao; Dabbous, Monique; Wang, Yitong; Han, Ru; Toumi, Mondher.

China has managed to control the coronavirus disease (COVID-19) with confinement measurements and treatment strategies, while other countries are struggling to contain the spread. This study discussesthe guidelines related to COVID-19 in China in order to provide important references for other countries ...

Betacoronavirus/efectos de los fármacos, Neumonía Viral/epidemiología, Infecciones por Coronavirus/epidemiología, China/epidemiología, Pandemias/prevención & control, Pandemias/estadística & datos numéricos, Monitoreo Epidemiológico, Gestión de la Información en Salud/métodos, Interferones/uso terapéutico, Lopinavir/uso terapéutico, Ritonavir/uso terapéutico, Ribavirina/uso terapéutico, Cloroquina/uso terapéutico, Infecciones por Coronavirus/tratamiento farmacológico, Neumonía Viral/tratamiento farmacológico

Texto completo